ArticleBMC cancer2015

Impact of kinesin Eg5 inhibition by 3,4-dihydropyrimidin-2(1H)-one derivatives on various breast cancer cell features.

Bruna C Guido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.